Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 401-420 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 401 | Vantor lowweak | Opp 1 Risk 1 | Thesis: Vantor's membership rationale suggests spatial-intelligence and constellation expansion relevance, but there are no retained evidence or article summaries within the recent evidence window to support a current opportunity thesis. Why now: Why now is weak because the reviewed sources contain no retained post-cutoff directional evidence. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without and cannot be cited directly here. |
| 402 | Varda Space Industries lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources confirms cohort relevance, but it contains no retained 90-day direct positive evidence to support a durable 1 year+ upside thesis. Why now: No within the recent evidence window company-specific evidence were available after filtering; articles after recent evidence window and evidence after recent evidence window are both zero in coverage data, so recency-based thesis formation is not supported in these reviewed sources. Caveats: 12 articles were considered historically, but zero article IDs remained after the 90-day recent evidence filter. Membership rationale cites older support article IDs but those underlying evidence are not retained in the served reviewed sources. Scores are constrained by evidence absence, not by a documented negative business development. |
| 403 | Venturi Astrolab lowweak | Opp 1 Risk 1 | Thesis: The phase-2 rationale references NASA moon buggy contracts and moon base planning tied to articles: and: which could have supported an opportunity case, but these reviewed sources provide no representative article details, or retained evidence after recent evidence window. Therefore no grounded positive thesis can be advanced here. Why now: Why now is weak because despite 30 articles considered, coverage data shows articles after recent evidence window of 0 and evidence recent evidence review kept_rows of 0, so the reviewed sources does not preserve dated supporting evidence inside the 90-day window. Caveats: Phase-2 rationale cannot substitute for cited article evidence because are absent. No direct positive or negative evidence arrays are populated. Low scores are driven by evidence retention limits in these reviewed sources. |
| 404 | Virgin Galactic Holdings, Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct positive evidence inside the scoring fields, so no positive investment thesis is supportable here. Why now: The phase2 rationale references three article IDs, but the reviewed sources includes no representative article summaries or evidence to cite for a dated catalyst. Coverage data shows zero article IDs after recent evidence window and zero available evidence, so the current-state thesis is unsupported by reviewed sources detail. Caveats: Do not infer direction from company identity or sector relevance alone. Phase2 membership support cannot substitute for direct thesis evidence. |
| 405 | Vyoma GmbH lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, even though membership rationale says Vyoma is an SDA company selected by ESA and flying SSA sensors. Why now: Why now is unsupported because the reviewed sources contain no surviving evidence after recent evidence filtering; timing and business-state changes cannot be validated from the provided material. Caveats: Zero evidence after recent evidence filtering. Membership rationale alone is not sufficient for directional scoring. No direct dated catalyst or adverse development is provided. |
| 406 | Windward Ltd. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources provide no direct positive company-specific evidence after recent evidence window. The only described context is that Vantor partnered with Windward for maritime awareness, but relations are context-only unless separately gated and cannot be used as counterparty propagation evidence. Why now: No catalyst is established. Coverage debug shows 27 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Relation context is explicitly weaker and not valid counterparty propagation evidence. |
| 407 | WISeKey International Holding Ltd lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates space-related operations through WISeSat, but provides no retained within the recent evidence window direct positive evidence or article to support an opportunity thesis. Why now: There are zero available evidence after recent evidence window for ranking, so no evidence-backed timing signal is available. Caveats: Membership support mentions 21 LEO satellites launched and operational space-related infrastructure, but those claims are not accompanied here by retained ranking evidence or article. Without dated evidence inside the recent evidence window, score should remain low-conviction. |
| 408 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: The membership rationale references public listing status and defense contract momentum, but no retained within the recent evidence window direct evidence or article summaries are available here to support a positive thesis. Why now: The reviewed sources have no retained dated evidence after the 90-day recent evidence window, so there is no citable timing edge for a 1 year+ ranking. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs and, but no or retained evidence text are provided here. Later-dated evidence could supersede older listing or contract-status claims, but no such retained evidence exists in these reviewed sources. |
| 409 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: The membership rationale suggests meaningful satellite-manufacturing and tactical-communications activity, but the reviewed sources retains no direct evidence within the recent evidence window to support a positive thesis. Why now: Although membership support cites articles, and: no representative summaries or retained evidence are included here, leaving no current catalyst basis. Caveats: 54 articles considered, but 0 retained after recent evidence filtering. Cannot elevate based on membership rationale alone. |
| 410 | Akashalabdhi lowweak | Opp 0 Risk 0 | Thesis: No positive thesis is supportable because the reviewed sources contain no direct positive evidence for Akashalabdhi within the recent evidence window. Why now: There is no visible near-term or long-horizon company-specific catalyst in the reviewed sources. The membership review explicitly says the only included article does not mention Akashalabdhi in the visible summary, and coverage debug shows zero articles and zero evidence after recent evidence window. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article. Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. The reviewed sources itself says visible evidence is insufficient to determine even qualifying membership. |
| 411 | Amentum Holdings Inc. lowweak | Opp 0 Risk 0 | Thesis: No positive thesis is supportable from retained reviewed sources evidence because there are no direct positive evidence and no articles retained after the 90-day recent evidence window. Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite large historical mention volume. Caveats: Phase-2 rationale references article IDs and, but no article summaries or retained evidence are included here. Historical aerospace exposure does not create a current directional thesis without retained evidence. |
| 412 | Apparition Geoservices GmbH lowweak | Opp 0 Risk 0 | Thesis: No positive thesis can be established because no direct positive evidence for Apparition Geoservices GmbH is available in the reviewed sources after recent evidence filtering. Why now: No current business-state change or catalyst is visible. Although 6 articles were considered, coverage debug shows 0 articles after recent evidence window and 0 evidence after recent evidence window, while the membership review says the reviewed sources are only a broad European tech funding roundup without a direct company-specific description. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Mention count and article count do not increase conviction because no post-recent evidence window evidence are available. Review-status rationale says retrieval context is insufficient for membership. |
| 413 | Arkeon lowweak | Opp 0 Risk 0 | Thesis: No positive thesis is supported because Arkeon has no direct positive evidence in the reviewed sources within the selected recent evidence window. Why now: No company-specific timing signal is visible. Coverage debug shows zero post-recent evidence window articles and evidence, and the membership note says only a generic funding-roundup article was available without a company-specific description tying Arkeon to the scope. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct event, fact, or negative development is available after recent evidence window. Low membership confidence is not directional evidence. |
| 414 | Ars Magna Semiconductors lowweak | Opp 0 Risk 0 | Thesis: No positive thesis can be formed because the reviewed sources includes no direct positive evidence for Ars Magna Semiconductors within the recent evidence window. Why now: There is no visible long-horizon strategic catalyst in the usable evidence. Coverage debug shows zero post-recent evidence window articles and evidence, and the only cited support is a general tech funding roundup without a company-specific description linking the company to the scope. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct positive or adverse operating evidence is available. Generic roundup context is weaker than company-specific evidence and is not directional proof. |
| 415 | Augusta Labs lowweak | Opp 0 Risk 0 | Thesis: No positive thesis is supportable because the reviewed sources have no direct positive evidence for Augusta Labs after recent evidence filtering. Why now: No current or durable catalyst can be identified from the reviewed sources. Coverage debug shows zero post-recent evidence window articles and evidence, and the membership note says the company is only present in a generic funding-roundup article without direct identification against the listed criteria. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Absence of risk evidence is not positive evidence. No direct company-specific facts or events are available. |
| 416 | BeatpulseLabs lowweak | Opp 0 Risk 0 | Thesis: No positive thesis can be justified because no direct positive evidence for BeatpulseLabs is present in the reviewed sources within the recent evidence window. Why now: There is no visible catalyst or deterioration signal. Coverage debug shows zero post-recent evidence window articles and evidence, and the only cited support is a generic funding-roundup article with no direct company-specific connection to the scope. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct event or fact evidence is available after recent evidence window. Generic context should not be treated as directional proof. |
| 417 | Bluestaq lowweak | Opp 0 Risk 1 | Thesis: No positive thesis is supported. The reviewed sources say Bluestaq is mentioned only through an executive's prior role at the company, which is indirect context rather than company-specific business evidence (: unavailable in reviewed sources). Why now: There is no clear why-now catalyst because the only reference is an indirect executive-background mention, with no direct event, product, contract, or financing evidence available. Caveats: No current evidence is provided for Indirect mention via an executive's prior role is not direct company evidence. Zero evidence available after recent evidence window. |
| 418 | Bose Corporation lowweak | Opp 0 Risk 0 | Thesis: No positive investment thesis can be supported because the reviewed sources contain no direct positive evidence for Bose Corporation after the 90-day recent evidence window. Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 97 articles considered but 0 articles after recent evidence window and 0 evidence available after dedupe; despite broad article consideration, nothing survived the time/evidence filters for a 1 year+ thesis judgment. Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept. |
| 419 | Breaking Change lowweak | Opp 0 Risk 0 | Thesis: No positive investment thesis can be supported because the reviewed sources contain no direct positive evidence for Breaking Change after the 90-day recent evidence window. Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 3 articles considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable. Caveats: Phase-2 membership rationale says the reviewed sources gives no meaningful company-specific evidence and references: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept. |
| 420 | CameraMatics lowweak | Opp 0 Risk 0 | Thesis: No positive thesis can be supported because there is no direct positive evidence for CameraMatics in the reviewed sources after recent evidence filtering. Why now: No company-specific catalyst is visible despite 6 articles considered, because coverage debug shows 0 articles after recent evidence window and 0 evidence after recent evidence window. The membership note says the reviewed sources only includes CameraMatics in a generic funding roundup with no direct statement tying it to the scope. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Article count does not create conviction because no post-recent evidence window evidence are available. No direct positive or adverse company-specific event is available. |
Risk view
Showing rows 381-400 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 381 | Spaceworks lowweak | Opp 1 Risk 1 | Thesis: No retained adverse evidence is provided, so no evidence-based risk thesis can be made. Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included. Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction. |
| 382 | SSC Space lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis is supportable from these reviewed sources because no direct negative evidence remains after recent evidence filtering. Why now: There is no retained within the recent evidence window evidence for a current catalyst. Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided. |
| 383 | ST Engineering lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Risk is limited to evidentiary uncertainty and boundary ambiguity around whether this specific activity is meaningful to ST Engineering's forward space thesis, not to a negative company event (: not provided in reviewed sources). Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported. Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence. |
| 384 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 1 | Thesis: There is also no direct adverse evidence retained inside the 90-day recent evidence window, so no material risk thesis is supported beyond normal uncertainty from missing current evidence. Why now: Why now is weak because the company had 10 articles considered, but zero article IDs and zero evidence remained after the 90-day recent evidence window cutoff of March 29, 2026; recency-based business-state judgment is therefore unavailable from these reviewed sources. Caveats: No retained evidence after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 membership rationale is not directional proof and cites support article IDs without, so it cannot be used as a fully cited factual thesis. |
| 385 | Starfighters Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Starfighters Space. Caveats: Phase-2 membership rationale references multiple article IDs, but the reviewed sources provide no article for citation. |
| 386 | Starfish Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources have no retained 90-day adverse evidence, so there is not enough for a risk thesis. Why now: No retained article IDs or evidence remain after recent evidence filtering, so there is no current evidence-based catalyst in the reviewed sources. Caveats: Single-article historical context is not retained within the recent evidence window. Absence of negative evidence is not positive evidence. Scoring is conservative because the current reviewed sources is effectively ungrounded for direction. |
| 387 | Starlab lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis is supportable because the reviewed sources retains no direct negative evidence within the recent evidence window. Why now: Why now is weak: the reviewed sources indicates zero evidence after recent evidence window, so there is no retained current catalyst or current operating-state evidence for Starlab. Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references, but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here. |
| 388 | StatSat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient company-specific adverse evidence to support a risk thesis. Why now: The membership rationale references article and says AISSat-4 is operated by StatSat, but no retained evidence or are present after recent evidence window, leaving recency and business impact uncertain. Caveats: The only described support is a limited operational reference, not a clear catalyst. No direct dated evidence row is retained in the reviewed sources. |
| 389 | Swedish Space Corporation lowweak | Opp 1 Risk 1 | Thesis: No material adverse company-specific evidence is available in the retained recent evidence window. Risk score is kept slightly above zero only because coverage is thin and business status is unconfirmed in the reviewed sources. Why now: There is no current catalyst supported by retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency and business-state changes cannot be assessed from these reviewed sources. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase2 rationale is weaker than direct company-specific event evidence and should not be treated as strong proof. |
| 390 | SWISSto12 lowweak | Opp 0 Risk 1 | Thesis: No material adverse evidence is shown. The low risk score reflects lack of documented negatives rather than evidence of resilience. Why now: There is no identifiable catalyst because the reviewed sources provide only a passing mention and no direct event or fact evidence. Caveats: No current evidence is provided for. Support level is provisional single-article context only. No evidence available after recent evidence window. |
| 391 | Swoop Technologies lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is present. The main risk is that the company may be only tangentially relevant to the targeted space themes, making the opportunity thesis weak rather than making the company negatively exposed (: not provided in reviewed sources). Why now: No inside-recent evidence window evidence are available, and the reviewed sources reports articles after recent evidence window = 0 and evidence after recent evidence window = 0, so there is no supported near-term or long-horizon timing catalyst beyond generic context. Caveats: Single-article company universe but no representative article content or provided. Contract-award framing comes only through membership rationale, not direct evidence. No materiality, scale, or timing detail is available. |
| 392 | TelePIX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available in the reviewed sources, but absence of current retained evidence means business execution, financing, and mission timing remain uncertain. Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window, so there is no current retained catalyst evidence in the last 90 days despite membership support referencing article Caveats: Support exists only in the membership rationale, which cites article: but no or article summary is provided in the reviewed sources, so it cannot be cited as a factual claim under the the evidence standard. Evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. |
| 393 | Telesat Corp lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is available in the reviewed sources, so there is not enough support for a material risk thesis. Why now: Coverage data reports zero article IDs after recent evidence window and zero evidence after recent evidence window, preventing a recency-based ranking call. Caveats: Membership rationale references satellite communications and Lightspeed progress, but no article or retained evidence are supplied for ranking use. Public company status does not itself create a thesis without evidence. |
| 394 | TESAT lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is present. The main limitation is evidentiary: TESAT's relevance may be real, but the reviewed sources does not provide company-specific directional evidence for either upside or downside (: not provided in reviewed sources). Why now: No inside-recent evidence window direct evidence are available, so there is no supported timing argument. Caveats: Relation evidence is context-only and cannot be propagated as direct contract evidence. No or representative article summary is provided. No company-specific materiality data is available. |
| 395 | TESAT Spacecom lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is provided; risk remains low because the reviewed sources contain only context-level mention. Why now: There is no within the recent evidence window direct company evidence. Membership rationale references, but no is provided and the support level is only provisional single-article context. Caveats: Support is explicitly supporting article context, not direct company-specific event evidence. No retained evidence after recent evidence window. Relations/context-only mentions cannot be used as counterparty propagation evidence. |
| 396 | Thales lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported by the reviewed sources. The more relevant issue is uncertainty over evidence attribution from Thales Alenia Space to Thales parent. Why now: There is no citable in-recent evidence window article summary or evidence row for Thales in these reviewed sources, and coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window. Caveats: Phase2 rationale references article ids: and: but no or summaries for them are included here. Parent/subsidiary propagation is explicitly uncertain in the reviewed sources rationale. No direct evidence were available after recent evidence window. |
| 397 | The ePlane Company lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available. The main downside is uncertainty about business fit, commercialization path, and whether the government-support reference is meaningful at the company level. Why now: The government RDI disbursal reference could matter on a 1 year+ horizon, but the reviewed sources lack timestamps, and direct evidence, limiting confidence in timing and materiality. Caveats: No current evidence is provided for Government support mention is contextual and not enough alone to prove commercial traction. Zero evidence available after recent evidence window. |
| 398 | Trishul Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Trishul Space. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Accelerator participation context is weaker than direct commercial, funding, or technical milestone evidence. |
| 399 | True Anomaly lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available. Risk remains low-scored due to lack of evidence rather than demonstrated business stability. Why now: Why-now is weak because the cited raise and mission activity appear only in membership rationale, without scoreable dated article details in the current evidence set. Caveats: Membership rationale cites, and, but the supporting articles are not available for direct use. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. A positive thesis requires positive evidence; membership rationale alone only supports a modest watchlist bias. |
| 400 | True Anomaly Centennial lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Risk remains low-scored only because evidence is absent, not because the business is proven safe. Why now: Why-now visibility is weak because the reviewed sources show zero evidence kept after recent evidence window for this company, so any claimed contract relevance lacks scoreable supporting detail in the current batch. Caveats: Reviewed evidence cites: in membership rationale but does not provide article summary or available evidence, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Absence of negative evidence is not positive evidence. |